Literature DB >> 21484428

IgG4-associated cholangitis with cholangiocarcinoma.

Beate K Straub1, Irene Esposito, Daniel Gotthardt, Boris Radeleff, Dalibor Antolovic, Christa Flechtenmacher, Peter Schirmacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21484428     DOI： 10.1007/s00428-011-1073-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  15 in total

1.  Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease?

Authors:  H SARLES; J C SARLES; R MURATORE; C GUIEN
Journal:  Am J Dig Dis       Date:  1961-07

2.  A case of pancreas cancer with autoimmune pancreatitis.

Authors:  Hiromu Inoue; Hiroyuki Miyatani; Yukihisa Sawada; Yukio Yoshida
Journal:  Pancreas       Date:  2006-08       Impact factor: 3.327

Review 3.  Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease.

Authors:  Yasser A Alderlieste; Bram D J van den Elzen; Erik A J Rauws; Ulrich Beuers
Journal:  Digestion       Date:  2009-04-20       Impact factor: 3.216

4.  Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.

Authors:  Raghuwansh P Sah; Suresh T Chari; Rahul Pannala; Aravind Sugumar; Jonathan E Clain; Michael J Levy; Randall K Pearson; Thomas C Smyrk; Bret T Petersen; Mark D Topazian; Naoki Takahashi; Michael B Farnell; Santhi S Vege
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

5.  IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis.

Authors:  Lizhi Zhang; Jason T Lewis; Susan C Abraham; Thomas C Smyrk; Stanley Leung; Suresh T Chari; John J Poterucha; Charles B Rosen; Christine M Lohse; Jerry A Katzmann; Tsung-Teh Wu
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

6.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

7.  Salivary duct carcinoma arising in IgG4-related autoimmune disease of the parotid gland.

Authors:  Jespal Gill; Neville Angelo; Mee Ling Yeong; Nick McIvor
Journal:  Hum Pathol       Date:  2009-02-05       Impact factor: 3.466

8.  Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis.

Authors:  Hyoung-Chul Oh; Jae Gyu Kim; Jeong Wook Kim; Kwang Sun Lee; Mi Kyung Kim; Kyong Choun Chi; Yong Seok Kim; Ki Hyun Kim
Journal:  Intern Med       Date:  2008-12-01       Impact factor: 1.271

9.  IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.

Authors:  Moon-Tong Cheung; Irene Lai-Oi Lo
Journal:  ANZ J Surg       Date:  2008-04       Impact factor: 1.872

10.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

Authors:  Amaar Ghazale; Suresh T Chari; Lizhi Zhang; Thomas C Smyrk; Naoki Takahashi; Michael J Levy; Mark D Topazian; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Keith Lindor; Michael B Farnell
Journal:  Gastroenterology       Date:  2007-12-07       Impact factor: 22.682
View more
  15 in total

Review 1.  Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.

Authors:  Hiep Nguyen Canh; Kenichi Harada
Journal:  Med Mol Morphol       Date:  2016-06-27       Impact factor: 2.309

2.  Immunoglobulin G4-mediated sclerosing cholangitis as a risk factor for cholangiocarcinoma: A case report.

Authors:  Karin E Koopman; Elisabeth Bloemena; Geert Kazemier; Michael Klemt-Kropp
Journal:  Mol Clin Oncol       Date:  2016-09-30

3.  Cholangiocarcinoma developed in a patient with IgG4-related disease.

Authors:  Akitoshi Douhara; Akira Mitoro; Emi Otani; Masanori Furukawa; Kosuke Kaji; Masakazu Uejima; Masayoshi Sawai; Motoyuki Yoshida; Hitoshi Yoshiji; Junichi Yamao; Hiroshi Fukui
Journal:  World J Gastrointest Oncol       Date:  2013-08-15

4.  A case of IgG4-related disease associated with diffuse large B cell lymphoma.

Authors:  Toshiyuki Mitsuyama; Akiyoshi Nishio; Makoto Takaoka; Kazushige Uchida; Masaaki Shimatani; Toshiro Fukui; Tsukasa Ikeura; Masaki Koyabu; Hideaki Miyoshi; Takeo Kusuda; Akiko Kurishima; Yuri Fukui; Kimi Sumimoto; Shinya Fujita; Yoshiko Uemura; Kazuichi Okazaki
Journal:  Clin J Gastroenterol       Date:  2012-11-27

5.  Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA).

Authors:  Jae Keun Park; Dongwuk Kim; Jeong Min Lee; Kwang Hyuck Lee; Kyu Taek Lee; Joo Kyung Park; Jong Kyun Lee
Journal:  J Pers Med       Date:  2022-05-24

Review 6.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

7.  Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor.

Authors:  Abbas Agaimy; Bruno Märkl
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

8.  Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan.

Authors:  Kazuichi Okazaki; Hisanori Umehara
Journal:  Int J Rheumatol       Date:  2012-05-29

Review 9.  Cholangiocarcinoma with respect to IgG4 Reaction.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2014-07-15

10.  Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma.

Authors:  Taku Tabata; Terumi Kamisawa; Seiichi Hara; Sawako Kuruma; Kazuro Chiba; Go Kuwata; Takashi Fujiwara; Hideto Egashira; Koichi Koizumi; Junko Fujiwara; Takeo Arakawa; Kumiko Momma; Masanao Kurata; Goro Honda; Koji Tsuruta; Takao Itoi
Journal:  Gut Liver       Date:  2013-02-07       Impact factor: 4.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.